Novo Nordisk Foundation Cellerator
- Advanced Therapies Week
- Partner
)
Novo Nordisk Foundation Cellerator – Let’s Close the Gap
Cellerator is dedicated to accelerating the development of cell therapies from concept to clinic. Built to address the persistent gap between scientific innovation and patient access, Cellerator enables the translation of promising research into real-world treatments.
Cellerator’s state of the art facility offers end-to-end support across diverse cell therapy platforms, including process development, analytical development, GMP manufacturing, regulatory documentation, and clinical trial enablement. Cellerators infrastructure and expertise empower biotech companies, pharmaceutical firms, and academic institutions to advance curative therapies to clinics efficiently and compliantly.
As a Novo Nordisk Foundation initiative, Cellerator fosters collaboration across sectors to drive progress in regenerative medicine. The mission is to make transformative therapies accessible to all patients, treating diseases at their root.
Cellerator is dedicated to accelerating the development of cell therapies from concept to clinic. Built to address the persistent gap between scientific innovation and patient access, Cellerator enables the translation of promising research into real-world treatments.
Cellerator’s state of the art facility offers end-to-end support across diverse cell therapy platforms, including process development, analytical development, GMP manufacturing, regulatory documentation, and clinical trial enablement. Cellerators infrastructure and expertise empower biotech companies, pharmaceutical firms, and academic institutions to advance curative therapies to clinics efficiently and compliantly.
As a Novo Nordisk Foundation initiative, Cellerator fosters collaboration across sectors to drive progress in regenerative medicine. The mission is to make transformative therapies accessible to all patients, treating diseases at their root.